Frank Torti
Director, Urovant Sciences Ltd.
Companies
- RoivantChair Jul 29, 2025 to now1
- Immunovant, Inc.Board member Dec 20, 2019 to now2
- RoivantPresident Jul 29, 2025 to Dec 19, 20251
- Arbutus BiopharmaBoard member Nov 27, 2018 to May 24, 20243
- Sio Gene Therapies Inc.Board member Oct 5, 2018 to Apr 19, 20214
- Myovant Sciences Ltd.Board member Nov 8, 2018 to Aug 27, 20195
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Roivant ROIV13,536,202 shares6$473.8M at $35.01Jun 30, 2026- Immunovant, Inc. IMVT1,009,228 shares7$27.7M at $27.45Apr 7, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 30, 2026Shares withheld for tax 40,310 shares at $35.39 of Roivant6
- Apr 7, 2026Granted 174,189 shares of Immunovant, Inc.7
- Mar 31, 2026Shares withheld for tax 160,035 shares at $27.70 of Roivant8
- Feb 23, 2026Sold 587,390 shares at $27.51 of Roivant9
- Feb 23, 2026Exercised options 587,390 shares at $3.85 of Roivant9
- Feb 20, 2026Sold 1,012,610 shares at $27.15 of Roivant9
- Feb 20, 2026Exercised options 1,012,610 shares at $3.85 of Roivant9
- Feb 19, 2026Sold 1,400,000 shares at $27.42 of Roivant9
- Feb 19, 2026Exercised options 1,400,000 shares at $3.85 of Roivant9
- Dec 24, 2025Gift 110,489 shares of Roivant10
- Dec 24, 2025Other 64,891 shares at $22.47 of Roivant10
- Dec 23, 2025Granted 175,380 shares at $22.45 of Roivant10
- Jul 30, 2025Granted 11,900,000 shares of Roivant11
- Jul 30, 2025Granted 1,836,547 shares of Roivant11
- Apr 1, 2025Granted 199,365 shares of Immunovant, Inc.12
- Apr 2, 2024Granted 120,400 shares of Immunovant, Inc.13
- Apr 12, 2023Granted 121,916 shares of Immunovant, Inc.14
- Sep 29, 2022Bought 20,000 shares at $5.81 of Immunovant, Inc.15
- Aug 17, 2022Granted 225,632 shares of Immunovant, Inc.16
- Jan 10, 2022Granted 100,126 shares of Immunovant, Inc.17
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARRoivant, Chair
- 2SEC EDGARImmunovant, Inc., Board member
- 3SEC EDGARArbutus Biopharma, Board member
- 4
- 5SEC EDGARMyovant Sciences Ltd., Board member
- 6
- 7
- 8SEC EDGARForm 4 filed Apr 2, 2026
- 9SEC EDGARForm 4 filed Feb 23, 2026
- 10SEC EDGARForm 4 filed Dec 29, 2025
- 11SEC EDGARForm 4 filed Aug 1, 2025
- 12SEC EDGARForm 4 filed Apr 3, 2025
- 13SEC EDGARForm 4 filed Apr 4, 2024
- 14SEC EDGARForm 4 filed Apr 14, 2023
- 15SEC EDGARForm 4 filed Sep 29, 2022
- 16SEC EDGARForm 4 filed Aug 19, 2022
- 17SEC EDGARForm 4 filed Jan 12, 2022